Generic HIV drugs to reach U.S.

Patents expiring, Indian firm prepared to flood market

Posted: December 5, 2017 at 1:54 a.m.

An employee operates a filtration machine inside a laboratory at a Laurus Labs Ltd. pharmaceutical plant in Visakhapatnam, Andhra Pradesh, India. The factory is preparing to churn out billions of generic pills for HIV patients.

Among the coconut plantations and beaches of South India, a factory the size of 35 football fields is preparing to churn out billions of generic pills for HIV patients and flood the U.S. market with the low-cost copycat medicines.

This story is only available from our archives.